中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共2条,第1-2条 帮助

条数/页: 排序方式:
Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK-Positive NSCLC Patients: eXalt3. 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  
Selvaggi, G.;  Wu, Y.;  Wang, Z.;  Wu, G.;  Poddubskaya, E.
  |  收藏  |  浏览/下载:121/0  |  提交时间:2021/05/17
ALK  NSCLC  ensartinib  
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:  
Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M.
  |  收藏  |  浏览/下载:128/0  |  提交时间:2020/11/30